Search results for "tissue repair"

showing 10 items of 28 documents

Formulation of Different Chitosan Hydrogels for Cartilage Tissue Repair

2014

Different formulations of Chitosan/sulphate and Chitosan/PEGDE were produced by physical and chemical reticulation to obtain hydrogels with better physiochemical properties. The hydrogels were analyzed – in terms of their non-toxicity, proliferative, differentiative, inflammatory and immunology responses. Commercial grade Chitosan (Sigma) was solubilized and purified by progressive filtrations. Then, the polymer was freeze-dried in a water soluble cationic form. A physical hydrogel was prepared by mixing a 3 % w/w water solution of the a.m. polymer with different stoichiometric ratios of (SO4=) 1/0.5;1/0.75;1/1 respectively. The hydrogels were cross-linked in multiwells. The chemical hydrog…

lcsh:Computer engineering. Computer hardwaretechnology industry and agriculturelcsh:TP155-156lcsh:TK7885-7895Chitosan Hydrogels Cartilage Tissue Repairmacromolecular substanceslcsh:Chemical engineering
researchProduct

Compromised Neurotrophic and Angiogenic Regenerative Capability during Tendon Healing in a Rat Model of Type-II Diabetes

2017

Metabolic diseases such as diabetes mellitus type-II (DM-II) may increase the risk of suffering painful connective tissue disorders and tendon ruptures. The pathomechanisms, however, by which diabetes adversely affects connective tissue matrix metabolism and regeneration, still need better definition. Our aim was to study the effect of DM-II on expressional changes of neuro- and angiotrophic mediators and receptors in intact and healing Achilles tendon. The right Achilles tendon was transected in 5 male DM-II Goto-Kakizaki (GK) and 4 age-matched Wistar control rats. The left Achilles tendons were left intact. At week 2 post-injury, NGF, BDNF, TSP, and receptors TrkA, TrkB and Nk1 gene expre…

Male0301 basic medicinePhysiologyGene Expressionlcsh:MedicineSubstance PCardiovascular PhysiologyTendonsEndocrinology0302 clinical medicineNerve Growth FactorMedicine and Health SciencesHomeostasisMedicinelcsh:ScienceMammalsAchilles tendonMultidisciplinarybiologyAnimal ModelsAnatomyReceptors Neurokinin-1musculoskeletal systemTendonmedicine.anatomical_structureExperimental Organism SystemsConnective TissueVertebratesAnatomyResearch ArticleNeurotrophinmedicine.medical_specialtyWistar RatsEndocrine DisordersNeovascularization PhysiologicConnective tissueResearch and Analysis MethodsRodentsAchilles Tendon03 medical and health sciencesModel OrganismsTendon InjuriesInternal medicineTissue RepairDiabetes MellitusGeneticsAnimalsReceptor trkBRats WistarReceptor trkABrain-derived neurotrophic factorWound Healingbusiness.industryBrain-Derived Neurotrophic Factorlcsh:RScleraxisOrganismsBiology and Life SciencesRatsTenomodulinDisease Models AnimalBiological Tissue030104 developmental biologyNerve growth factorEndocrinologyDiabetes Mellitus Type 2Metabolic DisordersAmniotesbiology.proteinlcsh:QAngiogenesisPhysiological Processesbusiness030217 neurology & neurosurgeryDevelopmental BiologyPLOS ONE
researchProduct

In vivo reprogramming for tissue repair.

2015

Berninger and colleagues define milestones for in vivo reprogramming and discuss recent developments in reprogramming into pancreatic b-cells and neurons. Vital organs such as the pancreas and the brain lack the capacity for effective regeneration. To overcome this limitation, an emerging strategy consists of converting resident tissue-specific cells into the cell types that are lost due to disease by a process called in vivo lineage reprogramming. Here we discuss recent breakthroughs in regenerating pancreatic β-cells and neurons from various cell types, and highlight fundamental challenges that need to be overcome for the translation of in vivo lineage reprogramming into therapy.

Cell typeLineage (genetic)Cell- and Tissue-Based TherapyAcinar CellsBiologyIn vivoInsulin-Secreting CellsmedicineHumansRegenerationCell LineagePancreasNeuronsBrain DiseasesRegeneration (biology)BrainPancreatic DiseasesTranslation (biology)Cell DifferentiationCell BiologyTissue repairCellular ReprogrammingCell biologymedicine.anatomical_structurePancreasReprogrammingNeurogliaNature cell biology
researchProduct

Biomaterials in periapical regeneration after microsurgical endodontics: A narrative review

2021

Background: The objective of this narrative review was to analyze the available scientific evidence regarding the application of biomaterials in endodontic microsurgery and its influence in post-surgical tissue repair. Material and Methods: The review question was Do biomaterials used in endodontic microsurgery influence post-surgical tissue repair and regeneration? Systematic MEDLINE/PubMed review was used to evaluate and present the results. Results: The search yielded 131 references, 82 of which were selected for full text review after reading the abstracts. After a manual search in the references of the articles selected, 52 references were eliminated. Finally, 30 articles were selected…

Bioactive endodontic cementsbusiness.industryRegeneration (biology)Endodontic microsurgeryDentistryReviewMicrosurgical endodonticsEndodontic surgeryTissue repairOperative Dentistry and EndodonticsEndodontic surgeryPeriapical repairMedicinePeriapical tissueNarrative reviewbusinessGeneral DentistryUNESCO:CIENCIAS MÉDICASJournal of Clinical and Experimental Dentistry
researchProduct

Recent Advances in Derivation of Functional Hepatocytes from Placental Stem Cells

2013

Abstract: End-stage liver diseases are one of the leading causes of death in the world. Often orthotopic liver transplantation represents the final therapeutic choice. The limits of this approach are the scarcity of donor livers available, and the many side effects related to the administration of immune suppressants to the patients. Cellular therapy for liver diseases is increasingly being viewed as a promising strategy to provide hepatocytes to replenish the parenchymal cells of the organ. This technique suffers of some important limitations, such as the difficulty in isolating sufficient cell numbers (e.g. when adult or foetal hepatocytes are used for transplantation), the limited viabil…

Hepatocyte differentiationMesenchymal stem cells Wharton’s jelly amniotic fluid amniotic membrane immune modulation umbilical cord hepatocyte differentiation functional assays inflammation fibrosis regenerative medicine tissue repair.Settore BIO/16 - Anatomia UmanaMesenchymal stem cellBiologyPlacenta cord bankingRegenerative medicineCell therapySettore MED/38 - Pediatria Generale E Specialisticamedicine.anatomical_structureDevelopmental NeuroscienceImmunologyCancer researchmedicineBone marrowStem cellDevelopmental BiologyAdult stem cellThe Open Tissue Engineering and Regenerative Medicine Journal
researchProduct

A New Absorbable Synthetic Substitute With Biomimetic Design for Dural Tissue Repair

2015

Dural repair products are evolving from animal tissue-derived materials to synthetic materials as well as from inert to absorbable features; most of them lack functional and structural characteristics compared with the natural dura mater. In the present study, we evaluated the properties and tissue repair performance of a new dural repair product with biomimetic design. The biomimetic patch exhibits unique three-dimensional nonwoven microfiber structure with good mechanical strength and biocompatibility. The animal study showed that the biomimetic patch and commercially synthetic material group presented new subdural regeneration at 90 days, with low level inflammatory response and minimal …

medicine.medical_specialtyMaterials scienceBiocompatibilityRegeneration (biology)Dura materBiomedical EngineeringMedicine (miscellaneous)Biomimetic designBioengineering02 engineering and technologyGeneral MedicineAdhesionTissue repair021001 nanoscience & nanotechnologySurgeryBiomaterials03 medical and health sciences0302 clinical medicinemedicine.anatomical_structuremedicineImplant0210 nano-technologyWound healing030217 neurology & neurosurgeryBiomedical engineeringArtificial Organs
researchProduct

C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-R…

2019

Background: Acute myocardial infarction (MI) elicits an inflammatory response that drives tissue repair and adverse cardiac remodeling. Inflammatory cell trafficking after MI is controlled by C-X-C motif chemokine ligand 12 (CXCL12) and its receptor, C-X-C motif chemokine receptor 4 (CXCR4). CXCR4 antagonists mobilize inflammatory cells and promote infarct repair, but the cellular mechanisms are unclear. Methods: We investigated the therapeutic potential and mode of action of the peptidic macrocycle CXCR4 antagonist POL5551 in mice with reperfused MI. We applied cell depletion and adoptive transfer strategies using lymphocyte-deficient Rag1 knockout mice; DEREG mice, which express a diphth…

Receptors CXCR4Regulatory T cellCXCR4 antagonistSus scrofaAnti-Inflammatory AgentsMyocardial InfarctionNeovascularization PhysiologicMice TransgenicInflammation030204 cardiovascular system & hematologyT-Lymphocytes RegulatoryVentricular Function Left03 medical and health sciencesChemokine receptor0302 clinical medicineImmune systemPhysiology (medical)medicineAnimalsMyocardial infarction030304 developmental biology0303 health sciencesMobilizationVentricular Remodelingbusiness.industryMyocardiumProteinsDendritic CellsRecovery of FunctionRegulatory T cellsTissue repairmedicine.diseaseMyocardial ContractionBlockadeMice Inbred C57BLDisease Models Animalmedicine.anatomical_structureCancer researchmedicine.symptomCardiology and Cardiovascular MedicinebusinessSignal TransductionCirculation
researchProduct

Tiratricol neutralizes bacterial endotoxins and reduces lipopolysaccharide-induced TNF-alpha production in the cell.

2008

Contains fulltext : 70610.pdf (Publisher’s version ) (Closed access) The screening of a commercially available library of compounds has proved a successful strategy for the identification of a lead compound in a drug discovery programme. Here, we analysed 880 off-patent drugs, which initially comprised the Prestwick Chemical library, as sources of bacterial endotoxin neutralizers. We identified 3,3',5-triiodo-thyroacetic acid (tiratricol) as a non-antibacterial compound that neutralizes the toxic lipopolysaccharide.

LipopolysaccharidesendotoxinLipopolysaccharideCelllipopolysaccharide-antagonistsBiology:Enginyeria dels materials [Àrees temàtiques de la UPC]BiochemistryCell LineChemical libraryMicrobiologyLipid ASepsissepsisMiceStructure-Activity Relationshipchemistry.chemical_compoundtumour necrosis factor-alphaDrug DiscoveryEscherichia colimedicineAnimalsDrugs--Designlipid APharmacologyTriiodothyroacetic acidMedicaments -- DissenyTumor Necrosis Factor-alphaDrug discoveryOrganic Chemistrylipopolysaccharidetumour necrosis factor-amedicine.diseaseAnti-Bacterial AgentsEndotoxinsmedicine.anatomical_structurechemistryTriiodothyronineMolecular Medicineseptic shockLead compoundImmunity infection and tissue repair [NCMLS 1]
researchProduct

Uptake of polyphosphate microparticles in vitro (SaOS-2 and HUVEC cells) followed by an increase of the intracellular ATP pool size

2017

Recently two approaches were reported that addressed a vitally important problem in regenerative medicine, i. e. the successful treatment of wounds even under diabetic conditions. Accordingly, these studies with diabetic rabbits [Sarojini et al. PLoS One 2017, 12(4):e0174899] and diabetic mice [Müller et al. Polymers 2017, 9, 300] identified a novel (potential) target for the acceleration of wound healing in diabetes. Both studies propose a raise of the intracellular metabolic energy status via exogenous administration either of ATP, encapsulated into lipid vesicles, or of polyphosphate (polyP) micro-/nanoparticles. Recently this physiological polymer, polyP, was found to release metabolic …

0301 basic medicineConfocal MicroscopyBioenergeticsPhysiologyPolymerslcsh:Medicine02 engineering and technologyTrifluoperazineBiochemistryAdenosine TriphosphateEndocrinologyPolyphosphatesSpectroscopy Fourier Transform InfraredMedicine and Health Scienceslcsh:ScienceStainingMicroscopySecretory PathwayMultidisciplinaryChemistryLight MicroscopyCell Staining021001 nanoscience & nanotechnologyEndocytosisMicrospheres3. Good healthCell biologyChemistryMacromoleculesCell ProcessesPhysical SciencesRabbits0210 nano-technologyIntracellularResearch Articlemedicine.drugEndocrine DisordersMaterials by StructureMaterials ScienceBioenergeticsResearch and Analysis MethodsEndocytosisCell Line03 medical and health sciencesTissue RepairDiabetes Mellitusotorhinolaryngologic diseasesmedicineAnimalsHumansCalcium metabolismWound Healinglcsh:RSpectrometry X-Ray EmissionBiology and Life SciencesCell BiologyPolymer Chemistrydigestive system diseasesIn vitroMetabolism030104 developmental biologySpecimen Preparation and TreatmentCell cultureMetabolic DisordersMicroscopy Electron ScanningCalciumlcsh:QEnergy MetabolismPhysiological ProcessesWound healingConfocal Laser MicroscopyPowder DiffractionPLOS ONE
researchProduct

New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells.

2013

Cardiomyopathies are still the first cause of death in the world. The identification of resident stem cells, comprising those derived from sub-endocardial stroma, suggests the possible self regeneration of the heart under autocrine/paracrine modulation in the cardiac microenvironment. Nevertheless, because of the limited in vivo regeneration potential of damaged cardiac tissue, the use of drugs and ultimately cardiac transplantation remain the common treatments of heart diseases and defects. The differentiative potential of embryonic and mesenchymal stem cells (MSCs) derived from different tissues (such as bone marrow and adipose tissue) was extensively explored in cell therapy for regenera…

Settore BIO/17 - IstologiaImmune modulationCardiologyMedicine (miscellaneous)Clinical uses of mesenchymal stem cellsHeart failureBiologyRegenerative MedicineRegenerative medicineWharton's jellyHumansWharton JellyTissue repairMesenchymal stem cellStem cell transplantation for articular cartilage repairSettore BIO/16 - Anatomia UmanaWharton's jellyRegeneration (biology)Mesenchymal stem cellMesenchymal Stem CellsGeneral MedicineHeart failure; Immune modulation; Mesenchymal stem cells; Regenerative medicine; Tissue repair; Wharton's jellyTransplantationCardiovascular DiseasesImmunologyCancer researchStem cell
researchProduct